Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance

Gynecologic Oncology

Volumn 115, Issue 3, 2009, Pages 354-356

  Mhawech Fauceglia, Paulette ^a   Herrmann, Francois R ^b   Wagner, Heidi ^a   Godoy, Heidi ^a   Odunsi, Kunle ^a   Cheney, Richard T ^a   Lele, Shashikant ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Gynecologic malignancies; Impact; Lymph node dissection; Patients prognosis

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; SQUAMOUS CELL CARCINOMA;

COST-BENEFIT ANALYSIS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING; POISSON DISTRIBUTION; PROSPECTIVE STUDIES;

EID: 70350567817     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.09.008     Document Type: Article

References (12)

1. Cancer Committee Report to the General Assembly of FIGO. Classification and staging of malignant tumor in the female pelvis. Int J Gynaecol Obstet: The official organ of the International federation of gynaecology and Obstetrics 1971;9:172-9.
2. Wolfson A.H., Sightler S.E., Markoe A.M., et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol. Oncol. 45 (1992) 142-146
3. Bristow R.E., Zahurak M.L., Alexander C.J., et al. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer 13 (2003) 664-672
4. Hirahatake K., Hareyama H., Sakuragi N., et al. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J. Surg. Oncol. 65 (1997) 82-87
5. Cawthorn S.J., Gibbs N.M., and Marks C.G. Clearance technique for the detection of lymph nodes in colorectal cancer. Br. J. Surg. 73 (1986) 58-60
6. Goldhirsch A., Glick J.H., gelber R.D., and Senn H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J. Natl. Cancer Inst. 90 (1998) 1601-1608
7. Van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and stage II breast cancer. Eur J Surg Oncol 2002;28:481-9.
8. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch. Pathol. Lab. Med. 124 (2000) 979-994
9. Hammond M.E., Fitzgibbons P.L., Compton C.C., et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how, and so what?. Arch. Pathol. Lab. Med. 124 (2000) 958-965
10. Kotanagi H., Fukuoka T., Shibata Y., et al. The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer. J. Surg. Oncol. 54 (1993) 252-254
11. Kim Y.M., Suh J.H., Cha H.J., et al. Additional lymph node examination from entire submission of residual mesenteric tissue in colorectal cancer specimens may not add clinical and pathologic relevance. Hum. Pathol. 38 (2007) 762-767
12. Brown H.G., Luckasevic T.M., Medich D.S., Celebrezze J.P., and Jones S.M. Efficacy of manual dissection of lymph nodes in colon cancer resections. Modern Pathol. 17 (2004) 402-406